ACT 2 (not disclosed)

Artemisinin-based combination therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACT 2 (not disclosed), covering 2014-02-03 to 2014-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children [Phase 3]